Cardiovascular Clinical Consult

Latest News

CV risk
Empagliflozin Reduces Risk of CV Death, Hospitalization for Heart Failure With Preserved Ejection Fraction

July 8th 2021

The EMPEROR-Preserved study investigated empagliflozin (Jardiance; Eli Lilly) for the treatment of heart failure with preserved ejection fraction.

pharmacist in mask
Pharmacists Are Key Allies in Reducing Risk of Diabetes, Cardiovascular Disease

February 3rd 2021

cardiovascular disease
American Heart Association Report Predicts COVID-19 Effects on Cardiovascular Disease Burden

January 28th 2021

blood pressure
Study: Blood Pressure Medications Safe for Patients With COVID-19

January 22nd 2021

Heart failure medications
FDA Panel Votes on Expanded Use of Heart Failure Drug

December 17th 2020

Latest CME Events & Activities

Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure With Preserved Ejection Fraction

View More

Redefining Optimal Therapy for Patients with Heart Failure with Reduced Ejection Fraction: Integrating New Guidelines, Emerging Agents, and Pharmacist-led Transitions of Care

1.5 Credits / Cardiology

View More

Targeting the Clinical Course of Hypertrophic Cardiomyopathy: Keeping a Beat on New and Emerging Therapies

2.0 Credits / Cardiology

View More

The Impact of PCSK9 Modulation on Cardiovascular Outcomes: Recent Advances and the Managed Care Implications

1.5 Credits / Cardiology

View More

Preventing and Managing Controlled Substance Diversion Across Health Care Settings

2.0 Credits / Law

View More

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

The Management of HFrEF With New and Emerging Mechanisms of Action: Updates for Pharmacists

1.5 Credits / Cardiology

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Recent Advances in Omega-3 Fatty Acids to Reduce Risk of ASCVD in Patients With Elevated Triglyceride Levels

0.75 Credit / Cardiology

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Introduction to Anticoagulation and the Appropriate Patient

1.0 Credit / Cardiology

View More

The Treatment Landscape and a Review of Approved DOAC Agents

1.0 Credit / Cardiology

View More

The Role of the Pharmacist in Optimizing DOAC Utilization Across Practice Settings

1.0 Credit / Cardiology

View More

Understanding the Challenges of Homozygous Familial Hypercholesterolemia

1.0 Credit / Cardiology

View More

Navigating the Therapeutic Landscape of Homozygous Familial Hypercholesterolemia

1.0 Credit / Cardiology

View More

Maximizing Patient Outcomes Through Pharmacist-Led Homozygous Familial Hypercholesterolemia Management

1.0 Credit / Cardiology

View More

Setting the Stage: An Introduction to Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction

1.0 Credit / Cardiology

View More

Soluble Guanylate Cyclase Stimulators in the Management of Worsening Heart Failure With Reduced Ejection Fraction

1.0 Credit / Cardiology

View More

Individualizing Care for Patients With Heart Failure: The Role of the Pharmacist in Optimizing Education and Improving Adherence

1.0 Credit / Cardiology

View More

Advancing Chronic Worsening Heart Failure Treatment: The Critical Role of Pharmacists in Therapy Integration

1.0 Credit / Cardiology

View More

More News

© 2023 MJH Life Sciences

All rights reserved.